1

Bausch + Lomb

#2314

Rank

$6.33B

Marketcap

CA Canada

Country

Bausch + Lomb
Leadership team

Mr. Joseph C. Papa (CEO & Director)

Mr. Osama A. Eldessouky (Exec. VP & CFO)

Ms. Christina M. Ackermann (Exec. VP, Gen. Counsel & Pres of Ophthalmic Pharmaceuticals)

Products/ Services
Health Care, Health Diagnostics, Medical
Number of Employees
1,000 - 20,000
Headquarters
Rochester, New York, United States
Established
1853
Company Registration
SEC CIK number: 0001860742
Net Income
100M - 500M
Revenue
Above - 1B
Traded as
BLCO
Social Media
Overview
Location
Summary
Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, and dry eye. The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of eye conditions, such as glaucoma, ocular hypertension, and retinal diseases; and contact lenses for therapeutic use. The Surgical segment provides tools and technologies for the treatment of cataracts, and vitreous and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices. The company was founded in 1853 and is headquartered in Vaughan, Canada.
History

Bausch + Lomb was founded in 1853 by two German immigrants, John Jacob Bausch and Henry Lomb. They began their venture by selling optical instruments in Rochester, New York, U.S.A. Over the years, the company has grown into a world leader in eye care products and solutions, and has become a symbol of quality and innovation.

Mission
Improving people’s lives with our health care products Bausch Health’s mission is supported by five pillars – guiding principles that are foundational to our success and future growth. They provide overall direction for the company and the tools necessary to rise to any challenge. Quality Health Care Outcomes: We are dedicated to delivering high-value, meaningful products and services that resonate with patients and prescribers. Bringing value to our stakeholders while delivering safe and effective products is at the heart of everything we do. Customer Focused: We measure ourselves and our actions through the lens of our customers and patients. We build strong relationships with customers and deliver on quality products and service. Innovation: Innovation is essential, as we search out new ways and continuously identify opportunities to design, develop and advance creative, ethical solutions that are timely and effective. Efficiency: Focus and execution enables us to drive productivity, leaving no stone unturned in identifying where we can make improvements and deliver value. We address the challenges of a changing market quickly and never compromise on quality. People: Our employees come to work each day focused on improving people’s lives. They are essential to the success of the organization. We strive to build and retain a strong team by recognizing and rewarding excellence, and by creating development opportunities.
Vision
To be your trusted health care partner
Key Team

Mr. Joseph F. Gordon (Pres of Global Consumer, Surgical & Vision Care)

Ms. Kelly Webber (Exec. VP & Chief HR Officer)

Dr. Yehia Hashad M.D. (Exec. VP of R&D and Chief Medical officer)

Mr. Louis W. Yu (Exec. VP & Chief Quality Officer)

Mr. Dennis Asharin (Exec. VP and Chief Global Manufacturing & Supply Chain Officer)

Recognition and Awards
Bausch + Lomb has won numerous awards over the years including the 2016 Prix Galien Excellence in Ophthalmology Award, the 2015 Julius Friedman Ophthalmic Innovation Prize and the 2012 Global Technology Innovation Award from Frost & Sullivan.
References
Bausch + Lomb
Leadership team

Mr. Joseph C. Papa (CEO & Director)

Mr. Osama A. Eldessouky (Exec. VP & CFO)

Ms. Christina M. Ackermann (Exec. VP, Gen. Counsel & Pres of Ophthalmic Pharmaceuticals)

Products/ Services
Health Care, Health Diagnostics, Medical
Number of Employees
1,000 - 20,000
Headquarters
Rochester, New York, United States
Established
1853
Company Registration
SEC CIK number: 0001860742
Net Income
100M - 500M
Revenue
Above - 1B
Traded as
BLCO
Social Media